| Drug Name |
Triamcinolone diacetate |
| Drug ID |
BADD_D02273 |
| Description |
Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis.[L8255] Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain,[L8264] or first line as a topical treatment of corticosteroid responsive dermatoses.[L8249] Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.[L8246,L8249,L8252,L8255,L8258,L8261,L8264]
Triamcinolone was granted FDA approval on 3 December 1957.[L8243] In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval[L38973] - for the treatment of patients with macular edema associated with uveitis.[L38963] |
| Indications and Usage |
For the treatment of perennial and seasonal allergic rhinitis. |
| Marketing Status |
Discontinued |
| ATC Code |
A01AC01; C05AA12; D07AB09; D07XB02; H02AB08; R01AD11; R03BA06; S01BA05 |
| DrugBank ID |
DB00620
|
| KEGG ID |
D00984
|
| MeSH ID |
C030262
|
| PubChem ID |
6216
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
38779-0166; 46439-8766; 52128-171; 62991-2175; 49452-7910 |
| Synonyms |
triamcinolone diacetate | Polcartolone | Polcortolon |
